T-DM1 Plus Non-Pegylated Liposomal Doxorubicin in HER2+ Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancers
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial
Cancers (Basel) 2020 Nov 25;[EPub Ahead of Print], E López-Miranda, JM Pérez-García, S Di Cosimo, E Brain, M Ravnik, S Escrivá-de-Romaní, M Vidal, J Gligorov, S Borštnar, L Calabuig, M Sampayo-Cordero, A Malfettone, A Llombart-Cussac, TM Suter, J CortésFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.